Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0029713 (
immaturity
)
4,335
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Using postmitotic granulocytes (PMGs) with low neutrophil alkaline phosphatase activity (
NAP
activity), factor(s) having the capacity to increase their
NAP
activity were examined in vitro. A high activity of the factor was demonstrated in the cystic fluid of a human squamous cell carcinoma, which is known to produce a large amount of granulocyte-macrophage colony-stimulating factor (GM-CSF). The
NAP
-stimulating factor increased
NAP
values both in PMGs from normal bone marrow and PMGs from patients with chronic myeloid leukemia (CML), and
NAP
values in cells treated with the factor approached or rose above those of normal peripheral granulocytes after 48 hr of culture. The effect of the factor was specific in that the factor caused stimulation only in granulocytic series. These findings may indicate that increases in
NAP
activity reflect maturation or granulocytes and that low
NAP
activity of neutrophils derived from patients with CML is due to the
immaturity
of these cells. The relationship between the factor responsible for the increase in
NAP
activity and GM-CSF is also discussed.
...
PMID:Factor(s) responsible for the increase in alkaline phosphatase activity of postmitotic granulocytes from normal individuals and patients with chronic myeloid leukemia. 697 95